Delivery Order SPE2DB20D2104-SPE2DB25FMWBL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,818.86 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order is...
- The Defense Logistics Agency awarded a $40,296.55 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Candesartan Cilexetil 32 mg, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, non-set-aside contract executed under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) with a ceiling value of $10,879.54. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count) with a ceiling value of $2,175.48. This is a firm fixed-price delivery order with no set-aside designation, placing of performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 10, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,915.76 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count units) under a firm fixed-price contract. The award was made on August 27, 2025, with an ultimate completion date of August 28, 2025, with performance to take place at the vendor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single...
- The Defense Logistics Agency awarded a $60,591.71 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in quantities of 90, with completion expected by September 5, 2025. This is a firm fixed price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a ceiling value of $13,581.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24,...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.69 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count units) with a firm fixed price structure. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, carries no set-aside designation and represents a competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 16 mg tablets (90-count) on August 27, 2025, with a ceiling value of $1,970.02. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified suppliers. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,131.43 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count) on July 30, 2025. This firm fixed-price delivery order, with a completion date of July 31, 2025, represents a non-competitive set-aside contract utilizing AmerisourceBergen's existing contractual relationship with DLA. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWBLDelivery Order
The Defense Logistics Agency awarded a $1,506.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this contract represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical distributor for federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support, enabling the company to supply a broad range of medications and medical supplies to military healthcare programs and other federal health systems worldwide. Candesartan cilexetil, an antihypertensive medication, represents one of the numerous pharmaceutical products the contractor delivers through this strategic partnership with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/22/25 |